Hjem › Fokal segmental glomerulosklerose › New York
Fokal segmental glomerulosklerose kliniske forsøg i New York
12 studier for Fokal segmental glomerulosklerose søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #27, Valhalla
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- New York Nephrology and Dialysis Access Surgery, PC, Clifton Park
- NYU Langone Nephrology Associates-Mineola, Mineola
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Columbia University Irving Medical Center- Site Number : 8400001, New York
- The Children's Hospital at Montefiore- Site Number : 8400027, The Bronx
RekruttererFase 2
Alder 16 til 75 · Alle køn · Opdateret 23. sep. 2026 · NCT06500702Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- Weill Cornell Medicine / NewYork-Presbyterian, New York
Rekrutterer
Op til 75 år · Alle køn · Opdateret 28. aug. 2026 · NCT04065438Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- Weill Cornell Medical Center / NewYork-Presbyterian, New York
Rekrutterer
Op til 21 år · Alle køn · Opdateret 28. aug. 2026 · NCT02235857Nephrotic Syndrome Study Network
- Cohen Children's Hospital, New Hyde Park
- New York University Medical Center, New York
- Bellevue Hospital, New York
- og 3 flere
RekruttererObservationsstudie
Op til 80 år · Alle køn · Opdateret 10. jun. 2026 · NCT01209000NEPTUNE Match Study
- Northwell/Cohen's Children's Hospital, New Hyde Park
- Columbia University Medical Center, New York
Rekrutterer
Alder 1 til 80 · Alle køn · Opdateret 10. jun. 2026 · NCT04571658Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Cohen Children's Medical Center, New Hyde Park
RekruttererFase 2
Alder 1 til 17 · Alle køn · Opdateret 12. maj 2026 · NCT05003986A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)
- Cohen Children's Medical Center, New Hyde Park
Rekrutterer
Alder 3 til 17 · Alle køn · Opdateret 17. apr. 2026 · NCT05583942taVNS for FRNS in Children
- Cohen Children's Medical Center, New Hyde Park
Rekrutterer
Alder 3 til 17 · Alle køn · Opdateret 15. apr. 2026 · NCT05588063AMPK-activation by Metformin in FSGS: AMP-FSGS
- Mount Sinai Hospital, New York
RekruttererFase 1/2
Alder 18 til 80 · Alle køn · Opdateret 3. feb. 2026 · NCT06090227A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- Icahn School of Medicine at Mount Sinai, New York
RekruttererFase 3
Alder 12 til 80 · Alle køn · Opdateret 3. feb. 2026 · NCT05183646Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.